Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106710124 | 10671012 | 4 | F | 20141211 | 20160711 | 20141223 | 20160715 | EXP | CN-ASTELLAS-2014US020778 | ASTELLAS | 45.08 | YR | M | Y | 0.00000 | 20160715 | CN | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106710124 | 10671012 | 1 | PS | TACROLIMUS. | TACROLIMUS | 1 | Oral | 2096 | MG | Y | 204096 | 8 | MG | MODIFIED-RELEASE CAPSULE, HARD | QD | ||||
| 106710124 | 10671012 | 2 | SS | TACROLIMUS. | TACROLIMUS | 1 | Unknown | UNK, UNKNOWN FREQ. | 2096 | MG | 1M4247D | 204096 | MODIFIED-RELEASE CAPSULE, HARD | ||||||
| 106710124 | 10671012 | 3 | SS | TACROLIMUS. | TACROLIMUS | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | 2096 | MG | 1M4266F | 204096 | MODIFIED-RELEASE CAPSULE, HARD | ||||||
| 106710124 | 10671012 | 4 | SS | TACROLIMUS. | TACROLIMUS | 1 | Unknown | UNK, UNKNOWN FREQ. | 2096 | MG | 1M4247D | 204096 | MODIFIED-RELEASE CAPSULE, HARD | ||||||
| 106710124 | 10671012 | 5 | SS | TACROLIMUS. | TACROLIMUS | 1 | Unknown | UNK, UNKNOWN FREQ. | 2096 | MG | 1M4281B | 204096 | MODIFIED-RELEASE CAPSULE, HARD | ||||||
| 106710124 | 10671012 | 6 | SS | TACROLIMUS. | TACROLIMUS | 1 | Unknown | UNK UNK, UNKNOWN FREQ. | 2096 | MG | 1M4266F | 204096 | MODIFIED-RELEASE CAPSULE, HARD | ||||||
| 106710124 | 10671012 | 7 | SS | TACROLIMUS. | TACROLIMUS | 1 | Oral | 1.5 MG IN THE MORNING, 1 MG IN THE EVENING | 2096 | MG | 1M4306F | 204096 | 2.5 | MG | MODIFIED-RELEASE CAPSULE, HARD | QD | |||
| 106710124 | 10671012 | 8 | SS | TACROLIMUS. | TACROLIMUS | 1 | Oral | 2096 | MG | OM4033G | 204096 | 2.5 | MG | MODIFIED-RELEASE CAPSULE, HARD | QD | ||||
| 106710124 | 10671012 | 9 | SS | ATG-FRESENIUS | LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN | 1 | Intravenous (not otherwise specified) | 550 MG, ONCE | 0 | 550 | MG | INJECTION | |||||||
| 106710124 | 10671012 | 10 | C | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | 208500 | MG | U | 0 | 750 | MG | TABLET | QD | ||||
| 106710124 | 10671012 | 11 | C | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | 208500 | MG | U | 0 | 480 | MG | TABLET | BID | ||||
| 106710124 | 10671012 | 12 | C | PREDNISON | PREDNISONE | 1 | Oral | 4020 | MG | U | 0 | 15 | MG | TABLET | QD | ||||
| 106710124 | 10671012 | 13 | C | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | Oral | 10 MG (DAILY DOSE), TWICE DAILY | U | 0 | 10 | MG | TABLET | BID | |||||
| 106710124 | 10671012 | 14 | C | BENAZEPRIL HYDROCHLORIDE. | BENAZEPRIL HYDROCHLORIDE | 1 | Oral | 10 MG (DAILY DOSE), TWICE DAILY | U | 0 | 10 | MG | TABLET | BID | |||||
| 106710124 | 10671012 | 15 | C | DILTIAZEM /00489702/ | 2 | Oral | 60 MG (DAILY DOSE), TWICE DAILY | U | 0 | 60 | MG | FORMULATION UNKNOWN | BID | ||||||
| 106710124 | 10671012 | 16 | C | ACARBOSE. | ACARBOSE | 1 | Oral | 150 MG (DAILY DOSE), THRICE DAILY | U | 0 | 150 | MG | FORMULATION UNKNOWN | TID | |||||
| 106710124 | 10671012 | 17 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | U | 0 | 500 | MG | FORMULATION UNKNOWN | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106710124 | 10671012 | 1 | Renal transplant |
| 106710124 | 10671012 | 9 | Renal transplant |
| 106710124 | 10671012 | 10 | Renal transplant |
| 106710124 | 10671012 | 12 | Renal transplant |
| 106710124 | 10671012 | 13 | Hypertension |
| 106710124 | 10671012 | 14 | Hypertension |
| 106710124 | 10671012 | 15 | Hypertension |
| 106710124 | 10671012 | 16 | Diabetes mellitus |
| 106710124 | 10671012 | 17 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106710124 | 10671012 | HO |
| 106710124 | 10671012 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106710124 | 10671012 | Diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 106710124 | 10671012 | 1 | 20140325 | 20141216 | 0 | |
| 106710124 | 10671012 | 2 | 20140307 | 20140425 | 0 | |
| 106710124 | 10671012 | 3 | 20140426 | 20140526 | 0 | |
| 106710124 | 10671012 | 4 | 20140527 | 20140627 | 0 | |
| 106710124 | 10671012 | 5 | 20140628 | 20140828 | 0 | |
| 106710124 | 10671012 | 6 | 20140828 | 20141216 | 0 | |
| 106710124 | 10671012 | 7 | 20141217 | 20141219 | 0 | |
| 106710124 | 10671012 | 8 | 20141220 | 0 | ||
| 106710124 | 10671012 | 9 | 20140307 | 20140307 | 0 | |
| 106710124 | 10671012 | 10 | 20140309 | 20141217 | 0 | |
| 106710124 | 10671012 | 11 | 20141218 | 0 | ||
| 106710124 | 10671012 | 12 | 20140319 | 20141217 | 0 |